Colorectal Cancer
Showing NaN - NaN of 143
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)
Not yet recruiting
- Colorectal Cancer
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 31, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)
Active, not recruiting
- Cutaneous Melanoma
- +5 more
-
Birmingham, Alabama
- +13 more
Jan 23, 2023
Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)
Recruiting
- Breast Cancer
- Colorectal Cancer
- Genetic Testing and Counseling
- Screening Form
-
Houston, TexasMD Anderson Cancer Center
Jan 20, 2023
a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Recruiting
- Colorectal Cancer
-
Phoenix, Arizona
- +46 more
Jan 18, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer
Active, not recruiting
- Colorectal Cancer
- mt-sDNA 2.0 screening test
- +2 more
-
Birmingham, Alabama
- +191 more
Jan 9, 2023
2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA
Active, not recruiting
- Colorectal Cancer
- Blood Sample Collection
-
Birmingham, Alabama
- +189 more
Jan 9, 2023
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)
Completed
- Non-small Cell Lung Cancer
- +9 more
- PF-06946860
- Placebo for PF-06946860
-
Little Rock, Arkansas
- +32 more
Dec 12, 2022
Ovarian Cancer, Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)
Recruiting
- Ovarian Cancer
- +2 more
- Genetic Testing and Counseling
- Screening Form
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029
Terminated
- Colorectal Cancer
- +6 more
- GEN1029 (HexaBody®-DR5/DR5)
-
New Haven, Connecticut
- +5 more
Nov 11, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T
Recruiting
- Breast Cancer
- +8 more
- P-MUC1C-ALLO1 CAR-T cells
- Rimiducid
-
San Francisco, California
- +4 more
Oct 26, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)
Active, not recruiting
- Colorectal Cancer
- Obinutuzumab
- +3 more
-
Los Angeles, California
- +12 more
Aug 19, 2022